ENvue Medical, Inc.
FEED
$1.16
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -56.79% | 46.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -56.79% | 46.15% | |||
| Cost of Revenue | 27.95% | 0.76% | |||
| Gross Profit | -295.77% | 640.00% | |||
| SG&A Expenses | 46.77% | -25.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.78% | -33.58% | |||
| Operating Income | -62.88% | 43.49% | |||
| Income Before Tax | -2,535.05% | 113.94% | |||
| Income Tax Expenses | -1,297.14% | -43.55% | |||
| Earnings from Continuing Operations | -2,620.00% | 112.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,620.00% | 112.84% | |||
| EBIT | -62.88% | 43.49% | |||
| EBITDA | -70.95% | 44.91% | |||
| EPS Basic | -1,261.40% | 11.95% | |||
| Normalized Basic EPS | -401.07% | 108.02% | |||
| EPS Diluted | -1,261.40% | 11.95% | |||
| Normalized Diluted EPS | -401.07% | 108.02% | |||
| Average Basic Shares Outstanding | 28.30% | 77.14% | |||
| Average Diluted Shares Outstanding | 28.30% | 77.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||